Catalog No.
MVV27902
Species reactivity
Classical swine fever virus (CSFV)
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Immunogen
Synthesized peptide.
Applications
ELISA, WB
Target
structural protein E1, structural protein E1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
NP_777497
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
1A034
Note
For research use only.
Antigenic structure of envelope glycoprotein E1 of hog cholera virus., PMID:7514680
Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection., PMID:8821642
Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge., PMID:8922467
Characterization of classical swine fever virus entry by using pseudotyped viruses: E1 and E2 are sufficient to mediate viral entry., PMID:15527858
Identification of antigenic regions of the Erns protein for pig antibodies elicited during classical swine fever virus infection., PMID:15671490
Novel marker vaccines against classical swine fever., PMID:17239502
Removal of a N-linked glycosylation site of classical swine fever virus strain Brescia Erns glycoprotein affects virulence in swine., PMID:17904607
The selection pressure analysis of classical swine fever virus envelope protein genes Erns and E2., PMID:17928086
Effect of N-glycosylation inhibition on the synthesis and processing of classical swine fever virus glycoproteins., PMID:18084653
Development of a live attenuated antigenic marker classical swine fever vaccine., PMID:19046591
Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope., PMID:19892497
Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins., PMID:21968199
Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture., PMID:22515281
[Expression and antiviral activity of a chimeric porcinized monoclonal antibody (cHQ06) against E2 protein of classical swine fever virus]., PMID:28853251
E2 and Erns of classical swine fever virus C-strain play central roles in its adaptation to rabbits., PMID:30607768
The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge., PMID:34730400
Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development. PMID: 19248137
Classical swine fever: genetic detection and analysis of differences between virus isolates. PMID: 7996138
Vaccination of chimpanzees against infection by the hepatitis C virus. PMID: 7509068
Processing of the envelope glycoproteins of pestiviruses. PMID: 8388499
For research use only. Not for human or drug use.
